Health & longevity
Key Questions
Why did the FDA recall Boston Scientific pacemakers?
The FDA recalled 1.3 million pacemakers due to battery failures linked to 4 deaths and 2,500 injuries. The action was escalated following reports of device malfunctions.
How do GLP-1 drugs affect physical activity?
A study using Fitbit data found that GLP-1 medications are associated with reduced physical activity levels. This raises questions about long-term lifestyle impacts.
What is the link between internet use and dementia risk?
Regular internet use is associated with a 43-58% lower risk of dementia. Morning light exposure above 1,000 lux is also linked to a 16% reduction in risk.
What new feature is coming to the NHS app?
An AI triage feature will be added to the NHS app to direct patients to appropriate services. It is expected to reduce phone queues by up to 29%.
How can sleep data predict diseases?
Stanford's SleepFM AI model can predict over 130 diseases from sleep patterns recorded by wearables. It analyzes heart rate, oxygen levels, and movement during rest.
What progress was made in vision recovery research?
Scientists found that mammalian brains can partially rewire after vision loss through collateral sprouting. Male mice showed faster recovery, suggesting potential sex-specific therapies for blindness.
Why were statins never tested on postmenopausal women?
Original statin trials excluded postmenopausal women, leaving gaps in data on estrogen's effects. New analysis highlights how estrogen alters drug metabolism and outcomes.
What data was released by the All of Us Research Program?
The program released 535,000 genomes and data from 68,000 Fitbit users. It now includes multiomics data to advance personalized health research.
Developing: FDA recalls 1.3M Boston Scientific pacemakers — 4 deaths, 2,500 injuries from battery failure. FDA warns 25 telehealth companies over compounded GLP-1 marketing claims. Study finds GLP-1 drugs reduce physical activity (Fitbit data). Regular internet use linked to 43-58% lower dementia risk. Morning light exposure (>1,000 lux) linked to 16% lower dementia risk. Underrepresented populations face greater privacy risks in AI training data. Smartphones may affect fertility. FDA may ease restrictions on peptides (BPC-157) despite thin evidence. All of Us Research Program releases 535K genomes, 68K Fitbit users — 8,000-9,000 steps threshold. FDA alert on Insulet Omnipod tubing tear — escalated to Class I recall (24 injuries, no deaths). Microdosing GLP-1s trending but no strong evidence yet. Vitamin K2 supplement may slow coronary artery calcification — statin paradox. NHS app gets AI triage feature — 29% fewer phone queues. Stanford's SleepFM predicts 130+ diseases from sleep data. Statins were never tested on postmenopausal women — estrogen-as-natural-statin analogy. New: Scientists discover mammalian brains can partially rewire after vision loss via collateral sprouting, with sex differences (male mice recover faster) — potential future therapies for blindness. Ongoing: Retatrutide compounding risks; Kimba AI scent therapy; Phone habits sleep disruption; Vivistim vagus nerve stimulator; sleep U-curve; glymphatic-HRV dementia link; smart toilet cancer detection; $2 morning habit for AFib; CDC sleep stats; KRAS pill for pancreatic cancer; Ozempic brain rewiring; APOE4 sleep optimization; Dexcom G7 recall.